In a preclinical study, a new jararaca antivenom serum was three times more effective than the standard one (IMAGE)

Fundação de Amparo à Pesquisa do Estado de São Paulo

In a preclinical study, a new jararaca antivenom serum was three times more effective than the standard one

Caption

Tashima, in the background, and three students who participated in the work: Claudia de Paula Santos, Jackelinne Yuka Hayashi and Isabel Sakanoue Leite

Credit

Daniel Antônio/Agência FAPESP

Usage Restrictions

No

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.